Evaluation of a probiotics, Bifidobacterium breve BBG-01, for enhancement of immunogenicity of an oral inactivated cholera vaccine and safety: a randomized, double-blind, placebo-controlled trial in Bangladeshi children under 5 years of age.

2011-02-24
RCT
Vaccine 29(10)
- F. Matsuda
- M. Chowdhury
- A. Saha
- T. Asahara
- K. Nomoto
- A. Tarique
- T. Ahmed
- M. Nishibuchi
- A. Cravioto
- F. Qadri

PubMed: 21236234
DOI: 10.1016/j.vaccine.2010.12.133

Altered Enteric Bacterial Flora

High evidence

A negative correlation between Bifidobacterium and Enterobacteriaceae in the probiotic group suggests a possible involvement of BBG-01 in alteration of the enteric bacterial flora.

Effect: Neutral
Effect size: Small

Bifidobacterium breve MAK40B22B and Altered Enteric Bacterial Flora

Evaluation of a probiotics, Bifidobacterium breve BBG-01, for enhancement of immunogenicity of an oral inactivated cholera vaccine and safety: a randomized, double-blind, placebo-controlled trial in Bangladeshi children under 5 years of age.